Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Recommendation of “Hold” by Brokerages

Hims & Hers Health, Inc. (NYSE:HIMS) has earned an average rating of “Hold” from the seventeen analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $24.80.

Several brokerages have issued reports on HIMS. Morgan Stanley started coverage on shares of Hims & Hers Health in a research note on Tuesday, December 17th. They set an “overweight” rating and a $42.00 target price on the stock. Canaccord Genuity Group upped their price target on Hims & Hers Health from $28.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, December 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research report on Wednesday, November 6th. Needham & Company LLC upped their target price on Hims & Hers Health from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday. Finally, Piper Sandler increased their price target on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday.

Insider Activity at Hims & Hers Health

In related news, insider Michael Chi sold 7,500 shares of the firm’s stock in a transaction on Monday, October 21st. The stock was sold at an average price of $22.20, for a total transaction of $166,500.00. Following the completion of the sale, the insider now directly owns 193,980 shares of the company’s stock, valued at $4,306,356. This trade represents a 3.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Soleil Boughton sold 268,932 shares of Hims & Hers Health stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $27.75, for a total value of $7,462,863.00. Following the completion of the transaction, the insider now directly owns 169,803 shares of the company’s stock, valued at $4,712,033.25. This represents a 61.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,333,446 shares of company stock valued at $34,175,197 over the last quarter. 17.71% of the stock is owned by company insiders.

Institutional Investors Weigh In On Hims & Hers Health

Several hedge funds and other institutional investors have recently made changes to their positions in HIMS. Principal Financial Group Inc. raised its stake in shares of Hims & Hers Health by 763.4% during the second quarter. Principal Financial Group Inc. now owns 143,793 shares of the company’s stock worth $2,903,000 after buying an additional 127,138 shares during the last quarter. Commonwealth Equity Services LLC bought a new stake in shares of Hims & Hers Health during the 2nd quarter valued at $479,000. Rhumbline Advisers lifted its stake in shares of Hims & Hers Health by 50.1% in the 2nd quarter. Rhumbline Advisers now owns 268,420 shares of the company’s stock valued at $5,419,000 after purchasing an additional 89,535 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Hims & Hers Health by 6.6% in the 2nd quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock valued at $393,000 after purchasing an additional 1,212 shares during the period. Finally, Arizona State Retirement System boosted its position in shares of Hims & Hers Health by 3.0% in the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock worth $815,000 after purchasing an additional 1,173 shares during the last quarter. 63.52% of the stock is owned by institutional investors and hedge funds.

Hims & Hers Health Stock Down 7.0 %

HIMS stock opened at $25.74 on Friday. The company has a 50-day simple moving average of $27.11 and a 200 day simple moving average of $21.62. The company has a market capitalization of $5.62 billion, a P/E ratio of 58.50 and a beta of 1.31. Hims & Hers Health has a fifty-two week low of $8.14 and a fifty-two week high of $35.02.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.26. The business had revenue of $401.56 million during the quarter, compared to analyst estimates of $382.20 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The company’s revenue was up 77.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.04) earnings per share. Equities analysts anticipate that Hims & Hers Health will post 0.29 EPS for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.